Patent · US Active

Antibodies against cancer antigen TMEFF2 and uses thereof

US7785816B2 · kind B2 · utility

1Cited by
1References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 10, 2007
Grant dateAug 31, 2010
Priority date—
Expiry dateNov 1, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/77
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.